Abstract
Background: Transcorneal electrical stimulation (TES) has been suggested as a possible treatment for retinitis pigmentosa (RP). Objective: To expand the safety assessment of repeated applications of an electrical current from a DTL-like electrode in patients with RP. Methods: This single-arm open label interventional safety trial included a total of 105 RP patients from 11 European centers, who received weekly TES for 6 months on 1 eye followed by observation for another 6 months without stimulation. The primary outcome measure was safety, indicated by the frequency and severity of adverse events. Secondary measures included intraocular pressure and central retinal thickness. Visual field and visual acuity were examined using the methods available at each site. Results: Dry eye sensation was the most common adverse event recorded (37.5%). Serious adverse events secondary to TES were not observed. Most adverse events were mild and all resolved without sequelae. The secondary outcome measures revealed no significant or clinically relevant changes. Conclusion: The present results confirm the excellent safety profile of TES. Transient dry eye symptoms were the most common adverse event.
References
1.
2.
Dor
H
. Beiträge zur Electrotherapie der Augenkrankheiten
. Graefes Arch Clin Exp Ophthalmol
. 1873
;19
(3
):316
–52
. 0721-832X3.
Schatz
A
, Röck
T
, Naycheva
L
, Willmann
G
, Wilhelm
B
, Peters
T
, et al. Transcorneal electrical stimulation for patients with retinitis pigmentosa: a prospective, randomized, sham-controlled exploratory study
. Invest Ophthalmol Vis Sci
. 2011
Jun
;52
(7
):4485
–96
.
[PubMed]
0146-04044.
Morimoto
T
, Miyoshi
T
, Matsuda
S
, Tano
Y
, Fujikado
T
, Fukuda
Y
. Transcorneal electrical stimulation rescues axotomized retinal ganglion cells by activating endogenous retinal IGF-1 system
. Invest Ophthalmol Vis Sci
. 2005
Jun
;46
(6
):2147
–55
.
[PubMed]
0146-04045.
Ni
YQ
, Gan
DK
, Xu
HD
, Xu
GZ
, Da
CD
. Neuroprotective effect of transcorneal electrical stimulation on light-induced photoreceptor degeneration
. Exp Neurol
. 2009
Oct
;219
(2
):439
–52
.
[PubMed]
0014-48866.
DeMarco
PJ
Jr, Yarbrough
GL
, Yee
CW
, McLean
GY
, Sagdullaev
BT
, Ball
SL
, et al. Stimulation via a subretinally placed prosthetic elicits central activity and induces a trophic effect on visual responses
. Invest Ophthalmol Vis Sci
. 2007
Feb
;48
(2
):916
–26
.
[PubMed]
0146-04047.
Pardue
MT
, Phillips
MJ
, Yin
H
, Sippy
BD
, Webb-Wood
S
, Chow
AY
, et al. Neuroprotective effect of subretinal implants in the RCS rat
. Invest Ophthalmol Vis Sci
. 2005
Feb
;46
(2
):674
–82
.
[PubMed]
0146-04048.
Schatz
A
, Pach
J
, Gosheva
M
, Naycheva
L
, Willmann
G
, Wilhelm
B
, et al. Transcorneal Electrical Stimulation for Patients With Retinitis Pigmentosa: A Prospective, Randomized, Sham-Controlled Follow-up Study Over 1 Year
. Invest Ophthalmol Vis Sci
. 2017
Jan
;58
(1
):257
–69
.
[PubMed]
0146-04049.
Katz
J
, Zeger
S
, Liang
KY
. Appropriate statistical methods to account for similarities in binary outcomes between fellow eyes
. Invest Ophthalmol Vis Sci
. 1994
Apr
;35
(5
):2461
–5
.
[PubMed]
0146-040410.
Elliott
DB
. The good (logMAR), the bad (Snellen) and the ugly (BCVA, number of letters read) of visual acuity measurement
. Ophthalmic Physiol Opt
. 2016
Jul
;36
(4
):355
–8
.
[PubMed]
0275-540811.
Bittner
AK
, Iftikhar
MH
, Dagnelie
G
. Test-retest, within-visit variability of Goldmann visual fields in retinitis pigmentosa
. Invest Ophthalmol Vis Sci
. 2011
Oct
;52
(11
):8042
–6
.
[PubMed]
0146-040412.
Willmann
G
, Schäferhoff
K
, Fischer
MD
, Arango-Gonzalez
B
, Bolz
S
, Naycheva
L
, et al. Gene expression profiling of the retina after transcorneal electrical stimulation in wild-type Brown Norway rats
. Invest Ophthalmol Vis Sci
. 2011
Sep
;52
(10
):7529
–37
.
[PubMed]
0146-040413.
Hanif
AM
, Kim
MK
, Thomas
JG
, Ciavatta
VT
, Chrenek
M
, Hetling
JR
, et al. Whole-eye electrical stimulation therapy preserves visual function and structure in P23H-1 rats
. Exp Eye Res
. 2016
Aug
;149
:75
–83
.
[PubMed]
0014-483514.
Fu
L
, Lo
AC
, Lai
JS
, Shih
KC
. The role of electrical stimulation therapy in ophthalmic diseases
. Graefes Arch Clin Exp Ophthalmol
. 2015
Feb
;253
(2
):171
–6
.
[PubMed]
0721-832X15.
Sehic
A
, Guo
S
, Cho
KS
, Corraya
RM
, Chen
DF
, Utheim
TP
. Electrical Stimulation as a Means for Improving Vision
. Am J Pathol
. 2016
Nov
;186
(11
):2783
–97
.
[PubMed]
0002-944016.
Afarid
M
, Torabi-Nami
M
, Zare
B
. Neuroprotective and restorative effects of the brain-derived neurotrophic factor in retinal diseases
. J Neurol Sci
. 2016
Apr
;363
:43
–50
.
[PubMed]
0022-510X17.
Miyake
K
, Yoshida
M
, Inoue
Y
, Hata
Y
. Neuroprotective effect of transcorneal electrical stimulation on the acute phase of optic nerve injury
. Invest Ophthalmol Vis Sci
. 2007
May
;48
(5
):2356
–61
.
[PubMed]
0146-040418.
Henrich-Noack
P
, Voigt
N
, Prilloff
S
, Fedorov
A
, Sabel
BA
. Transcorneal electrical stimulation alters morphology and survival of retinal ganglion cells after optic nerve damage
. Neurosci Lett
. 2013
May
;543
:1
–6
.
[PubMed]
0304-394019.
Morimoto
T
, Miyoshi
T
, Sawai
H
, Fujikado
T
. Optimal parameters of transcorneal electrical stimulation (TES) to be neuroprotective of axotomized RGCs in adult rats
. Exp Eye Res
. 2010
Feb
;90
(2
):285
–91
.
[PubMed]
0014-483520.
Rojas
B
, Gallego
BI
, Ramírez
AI
, Salazar
JJ
, de Hoz
R
, Valiente-Soriano
FJ
, et al. Microglia in mouse retina contralateral to experimental glaucoma exhibit multiple signs of activation in all retinal layers
. J Neuroinflammation
. 2014
Jul
;11
(1
):133
.
[PubMed]
1742-209421.
Ma
Z
, Cao
P
, Sun
P
, Li
L
, Lu
Y
, Yan
Y
, et al. Optical imaging of visual cortical responses evoked by transcorneal electrical stimulation with different parameters
. Invest Ophthalmol Vis Sci
. 2014
Jul
;55
(8
):5320
–31
.
[PubMed]
0146-040422.
Kurimoto
T
, Oono
S
, Oku
H
, Tagami
Y
, Kashimoto
R
, Takata
M
, et al. Transcorneal electrical stimulation increases chorioretinal blood flow in normal human subjects
. Clin Ophthalmol
. 2010
Dec
;4
:1441
–6
.
[PubMed]
1177-5467© 2020 S. Karger AG, Basel
2019
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
